- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02748551
A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer
Prospective Multicenter Study on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery for Locally Advanced Gastric Cancer
Nowadays, the proportion of patients with locally advanced gastric cancer is estimated up to 90 percent of all gastric cancer cases in Russian Federation. Surgical procedure with D2 Lymphadenectomy is the main option for treatment. Conventional open approach is still the current standard for advanced gastric cancer. Laparoscopic procedures for gastric cancer as minimally invasive surgery has gained popularity for the treatment of early gastric cancer in East Asia. Several studies indicated that laparoscopic procedures both total and subtotal gastrectomy with D2 lymphadenectomy is a technically feasible and safe procedure by experienced surgeons in high-volume specialized hospitals. However, lack of solid evidence on the oncologic efficacy.
Starting clinical trials for evaluate safety of oncology laparoscopic subtotal gastrectomy for locally advanced gastric cancer. Aim of this trial is show safety, feasibility and oncologic efficacy of Laparoscopic radical surgical procedures both total and subtotal gastrectomy for treatment gastric cancer.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Anticipado)
Fase
- Fase 3
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Igor Khathov, MD, PhD
- Número de teléfono: 8 (495) 3042908
- Correo electrónico: ihatkov@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Roman Izrailov, MD, PhD
- Número de teléfono: 8 (495) 3042908
- Correo electrónico: izrailev@mail.ru
Ubicaciones de estudio
-
-
-
Lipetsk, Federación Rusa
- Reclutamiento
- Lipetsk regional oncological center
-
Contacto:
- Michail Lando, MD, PhD
- Correo electrónico: abdlan@yandex.ru
-
Moscow, Federación Rusa, 111123
- Reclutamiento
- Moscow Clinical Scientific Center
-
Contacto:
- Roman Izrailov, MD, PhD
- Número de teléfono: 8 (495) 3042908
- Correo electrónico: izrailev@mail.ru
-
Contacto:
- Boris Pomortsev, MD
- Número de teléfono: 8(915)2107630
- Correo electrónico: b.pomortsev@mknc.ru
-
Sub-Investigador:
- Michail Prostov
-
Moscow, Federación Rusa
- Reclutamiento
- Moscow Oncology Hospital 62
-
Contacto:
- Pavel Kononets
- Correo electrónico: p.kononets@onco62.ru
-
Moscow, Federación Rusa
- Reclutamiento
- P.Herzen Moscow Oncological Research Institute
-
Contacto:
- Andrey Ryabov, MD, PhD
- Correo electrónico: ryabovdoc@mail.ru
-
Moscow, Federación Rusa
- Reclutamiento
- Treatment and Rehabilitation Centre of Health Ministry of Russia
-
Contacto:
- Vladimir Lyadov, MD, PhD
- Correo electrónico: vlyadov@gmail.com
-
St. Petersburg, Federación Rusa
- Reclutamiento
- Leningradsky oncological center
-
Contacto:
- Andrey Pavlenko, MD, PhD
- Correo electrónico: andrewpavlenko@yandex.ru
-
St.Petersburg, Federación Rusa
- Reclutamiento
- Federal Medical Biology Agence №122 the name of L.Soko
-
Contacto:
- Victor Kashchenko, MD, PhD
- Correo electrónico: med@fromru.com
-
St.Petersburg, Federación Rusa
- Reclutamiento
- N. Petrov National Research Institute of Oncology
-
Contacto:
- Alexey Karachun, MD, PhD
- Correo electrónico: dr.a.karachun@gmail.com
-
-
-
-
-
Kiev, Ucrania
- Reclutamiento
- Lisod clinic
-
Contacto:
- Sergey Baydo, MD, PhD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- ECOG 0-1
- ASA I-III
- Histologically proven cancer of the stomach cT 2-4a(clinical stage tumor), N0-3, M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition
- Preoperative examination with no distant metastasis, no significantly enlarged lymph nodes around abdominal main artery, and tumor not a direct violation of the pancreas, spleen and other surrounding organs
- The gastric tumors are located in the stomach, are macroscopically resectable by subtotal or total gastrectomy with D2 lymph node dissection.
- Written informed consent
Exclusion Criteria:
- Clinically apparent distant metastasis
- Free cancer cells
- Bulky lymph node metastasis is detected by abdominal CT
- Previous treatment with radiation therapy for any tumors.
- Previous surgery for the present disease
- Pregnancy
- Psychiatric disease
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Laparoscopic surgery
Traditional open procedure for patient with locally advanced gastric cancer
|
Open surgery
|
Comparador activo: Open surgery
Minimum invasive procedure (laparoscopic) for patient with locally advanced gastric cancer
|
Laparoscopic surgery
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
"Major" Surgical Morbidity
Periodo de tiempo: 21 days.
|
"Major" Surgical morbidity is defined as the complication grade on III-V Clavien-Dindo Classification which occurs with-in postoperative 21 days, extension of hospitalization and re-hospitalization.
It is necessary to evaluate the complication and if it occurs during the hospitalization, it is required to record complication name, date of on-set (postoperatively), grade on Clavien-Dindo Classification and treatment for complication.
|
21 days.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
3-year progression-free survival
Periodo de tiempo: 36 months
|
In terms of locally advanced gastric cancer, to evaluate the progression-free survival rate in laparoscopic gastrectomy with D2 lymph node dissection at postoperative 3 years compared with open procedures
|
36 months
|
3-year overall survival
Periodo de tiempo: 6, 12, 18, 24, 30 and 36 months
|
In terms of locally advanced gastric cancer, to evaluate the overall survival rate in laparoscopic gastrectomy with D2 lymph node dissection at postoperative 3 years compared with open procedures
|
6, 12, 18, 24, 30 and 36 months
|
5-year overall survival rate
Periodo de tiempo: 6, 12, 18, 24, 30, 36, 48 and 60 months
|
In terms of locally advanced gastric cancer, to evaluate the overall survival rate in laparoscopic gastrectomy with D2 lymph node dissection at postoperative 5 years compared with open procedures
|
6, 12, 18, 24, 30, 36, 48 and 60 months
|
Surgical Mortality
Periodo de tiempo: 90 days
|
It is defined as the death within postoperative 90 days regardless of postoperative reason.
|
90 days
|
Peri-operative blood loss
Periodo de tiempo: 1 day
|
Minimally-invasive surgery is associated with less peri-operative blood loss.
Blood loss will be measured in milliliters and average blood loss will be compared to the conventional 'open' group.
|
1 day
|
Postoperative recovery index
Periodo de tiempo: 10 days
|
Time to first ambulation, flatus, liquid diet, soft diet, and duration of hospital stay are used to assess the postoperative recovery course The amount of abdominal drainage and blood transfusion are also recorded
|
10 days
|
Pain scores
Periodo de tiempo: up to 3 days after surgery
|
Pain scores based on a visual analog scale the day of surgery and the subsequent 3 days postoperative 1 days, 2 days, 3 days
|
up to 3 days after surgery
|
Postoperative quality of life
Periodo de tiempo: 6, 12, 18, 24, 30 and 36 months
|
Both the European Organization for Research and Treatment of Cancer (EORTC) C30 and STO22 are analyzed with quality of life
|
6, 12, 18, 24, 30 and 36 months
|
long-term surgical morbidity
Periodo de tiempo: 21days - 36 months after surgery
|
Surgical morbidity is defined as the events which occurs with-in postoperative 21 days - 36 months after surgery.
It is necessary to evaluate the complication, it is required to record complication name, date of on-set.
Long complications are included: hernia, bleeding, bowel obstruction etc.
|
21days - 36 months after surgery
|
Extent of lymph node dissection
Periodo de tiempo: 2 weeks
|
The extent of lymph node dissection in treatment of gastric cancer is considered a prognostic marker for postoperative survival and disease-free survival.
Before implementation of a new surgical technique, it is imperative that this technique is non-inferior with regard to the extent of lymph node dissection.
Measures will include the number of resected lymph nodes and the number of resected lymph node stations.
|
2 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Michail Byachov, MD, PhD, Moscow Clinical Scientific Center
- Silla de estudio: Roman Izrailov, MD, PhD, Moscow Clinical Scientific Center
- Investigador principal: Boris Pomortsev, MD, Moscow Clinical Scientific Center
- Investigador principal: Pavel Kononets, MD, PhD, Moscow Oncological Hospital 62
- Investigador principal: Andrey Ryabov, MD, PhD, P.Herzen Moscow Oncological Research Institute
- Investigador principal: Vladimir Lyadov, MD, PhD, Treatment and Rehabilitation Centre of Health Ministry of Russia
- Investigador principal: Alexey Karachun, MD, PhD, N. Petrov National Research Institute of Oncology
- Investigador principal: Victor Kashchenko, MD, PhD, Federal Medical Biology Agence №122 the name of L.Sokolov
- Investigador principal: Andrey Pavlenko, MD, PhD, Leningradsky oncological center
- Investigador principal: Michail Lando, MD, PhD, Lipetsk regional oncological center
- Investigador principal: Sergey Baydo, MD, PhD, Lisod clinic Kiev
- Director de estudio: Igor Khatkov, MD, PhD, Moscow Clinical Scientific Center
- Investigador principal: Michail Prostov, Moscow Clinical Scientific Center
- Investigador principal: Kirill Schostka, MD, PhD, Leningradsky oncological center
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- MKNC 01/2016
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Cáncer gástrico
-
Abramson Cancer Center of the University of PennsylvaniaTerminadoPaciente con cancerEstados Unidos
-
Peking Union Medical College HospitalTerminadoEncuesta | Estado nutricional | Paciente con cancerPorcelana
-
Ankara Medipol UniversityReclutamientoCuidados personales | Inmunoterapia | Manejo de síntomas | Paciente con cancerPavo
-
Northwestern UniversityGenzyme, a Sanofi CompanyRetiradoCANCER DE PROSTATAEstados Unidos
-
Fundacao ChampalimaudTerminado
-
University College London HospitalsTerminado
-
GenSpera, Inc.RetiradoCancer de prostata.Estados Unidos
-
University of Colorado, DenverColorado State UniversityRetiradoRealidad virtual | Diagnóstico por imagen | Educación del paciente | Paciente con cancerEstados Unidos
-
Dana-Farber Cancer InstituteTerminadoCancer de RIÑON | Cancer de prostata | Cáncer genitourinarioEstados Unidos
-
Rabin Medical CenterReclutamiento
Ensayos clínicos sobre Open Surgery
-
Istituti Clinici Scientifici Maugeri SpATerminadoEnfermedad de ParkinsonItalia
-
Seattle Children's HospitalJohns Hopkins University; Duke University; Vanderbilt University; University of Utah y otros colaboradoresReclutamientoEscoliosis idiopática | Espondilolistesis | Escoliosis; Adolescencia | Cifosis | Juvenil; Escoliosis | Escoliosis; CongénitaEstados Unidos
-
Mansoura UniversityDesconocido
-
AGO Study GroupCancer Research UK; ARCAGY/ GINECO GROUP; Grupo Español de Investigación en Cáncer... y otros colaboradoresTerminadoCáncer de ovarios | Cáncer de trompa de Falopio | Cáncer de cavidad peritonealEspaña, Francia, Dinamarca, Bélgica, Alemania, Austria, Porcelana, Italia, Corea, república de, Noruega, Suecia, Reino Unido
-
Kocaeli Derince Education and Research HospitalKocaeli UniversityDesconocidoRecuperación mejorada después de la cirugía | Cirugía a corazón abiertoPavo
-
University of TriesteTerminado
-
Dr. Faruk SemizInscripción por invitación
-
National Cancer Centre, SingaporeTerminadoEnfermedades de la tiroidesSingapur
-
University of PittsburghTerminado
-
Ethicon Endo-SurgeryTerminadoObesidadEstados Unidos, Alemania